Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926 Approval was based on CAPItello-291, a randomized, double-blind, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results